Načítá se...
Immune evasion by cancer stem cells
Tumor immunity represents a new avenue for cancer therapy. Immune checkpoint inhibitors have successfully improved outcomes in several tumor types. In addition, currently, immune cell-based therapy is also attracting significant attention. However, the clinical efficacy of these treatments requires...
Uloženo v:
| Vydáno v: | Regen Ther |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Japanese Society for Regenerative Medicine
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7966825/ https://ncbi.nlm.nih.gov/pubmed/33778133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.reth.2021.02.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|